A glimpse of light in humanity’s fight against the coronavirus pandemic seems to be peeking out as several countries plan for mass vaccination.
While Western countries chose to start with their own vaccines, other lower and middle-income countries would like to take on the Chinese ones.
One of China’s leading vaccine makers, Sinovac, has been reported to secure supply deals with several countries, including Indonesia, Turkey, Brazil, and Chile, and is holding talks with the Philippines for a potential sale. Indonesia and Brazil have already received their first shipment.
Preliminary clinical results of two vaccine candidates made by Chinese firms Sinovac and Sinopharm have proven safe and effective among participants but there might be other reasons behind the international purchase.
The potential distribution limitations of the Pfizer and Moderna vaccines have left a hole in the global supply that may be filled by Chinese vaccine makers.